Pregnancy in recipients of solid organs - Effects on mother and child

New England Journal of Medicine

Volumn 354, Issue 12, 2006, Pages 1281-1293

  McKay, Dianne B ^a   Josephson, Michelle A ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; DEXAMETHASONE; HYDROCORTISONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORTHOCLONE; PREDNISONE; RAPAMYCIN; THALIDOMIDE; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE;

ALLOGRAFT; BONE MARROW SUPPRESSION; BREAST FEEDING; CONGENITAL MALFORMATION; DRUG METABOLISM; FEMALE INFERTILITY; FETOTOXICITY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALFORMATION SYNDROME; ORGAN DONOR; ORGAN TRANSPLANTATION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; BREAST FEEDING; FEMALE; FERTILITY; FETUS; GRAFT REJECTION; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; ORGAN TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH;

EID: 33645101846     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra050431     Document Type: Review

References (126)

1. Murray JE, Reid DE, Harrison JH, Merrill JP. Successful pregnancies after human renal transplantation. N Engl J Med 1963;269:341-3.
2. Kaufman JJ, Dignam W, Goodwin WE, Martin DC, Goldman R, Maxwell MH. Successful, normal childbirth after kidney homotransplantation. JAMA 1967;200:338-41.
3. Stratta P, Canavese C, Giacchino F, Mesiano P, Quaglia M, Rossetti M. Pregnancy in kidney transplantation: satisfactory outcomes and harsh realities. J Nephrol 2003;16:792-806.
4. Pregnancy and renal disease. Lancet 1975;2:801-2.
5. Davision JM, Baylis C. Renal disease. In: de Swiet M, ed. Medical disorders in obstetric practice. 4th ed. Malden, Mass.: Blackwell Science, 2002:198-266.
6. Ross L. Ethical considerations of pregnancy in the female transplant recipient. N Engl J Med 2006;354:1313-6.
7. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. In: Cecka JM, Terasaki PI, eds. Clinical transplants 2004. Los Angeles: UCLA Immunogenetics Center, 2004:103-19.
8. Briggs JD, Jager K. The first year of the new ERA-EDTA Registry. Nephrol Dial Transplant 2001;16:1130-1.
9. Sibanda N, Briggs JD, Davison JM, Johnson RJ, Rudge CJ. Outcomes of pregnancy after renal transplantation: a report of UK Transplant Pregnancy Registry. Hypertens Pregnancy 2004;23:Suppl 1:136. abstract.
10. Davison JM, Redman CWG. Pregnancy post-transplant: the establishment of a UK registry. Br J Obstet Gynaecol 1997;104:1106-7.
11. Rizzoni G, Ehrich JHH, Broyer M, et al. Successful pregnancies in women on renal replacement therapy: report from the EDTA Registry. Nephrol Dial Transplant 1992;7:279-87.
12. Davison JM, Lind T, Uldall PR. Planned pregnancy in a renal transplant recipient. Br J Obstet Gynaecol 1976;83:518-27.
13. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. In: Cecka JM, Terasaki PI, eds. Clinical transplants 2002. Los Angeles, UCLA Immunogenetics Center, 2002:121-30.
14. Davison JM. Renal disease. In: de Swiet M, ed. Medical disorders in obstetric practice. Oxford, England: Blackwell Scientific Publications, 1984:192-259.
15. Davison JM, Katz AI, Lindheimer MD. Kidney disease and pregnancy: obstetric outcome and long-term renal prognosis. Clin Perinatol 1985;12:497-519.
16. Davison JM. Rein et grossesse: revue generale. Le Journal Internationale de Medicine 1985;10:38-51.
17. Davison JM. Pregnancy in renal allograft recipients: prognosis and management. Baillieres Clin Obstet Gynaecol 1987;1:1027-45.
18. Davison JM, Baylis C. Renal disease. In: de Swiet M, ed. Medical disorders in obstetric practice. 3rd ed. Oxford, England: Blackwell Scientific Publications, 1996:226-305.
19. Davison JM, Lindheimer MD. Renal disorders. In: Creasy RK, Resnik R, Iams JD, eds. Maternal-fetal medicine: principles and practice. 5th ed. Philadelphia: W.B. Saunders, 2004:901-24.
20. Davison JM, Baylis C. Pregnancy in patients with underlying renal disease. In: Davison JM, Cameron JS, Ritz E, et al., eds. Oxford textbook of clinical nephrology. 3rd ed. Oxford, England: Oxford University Press, 2005:2243-60.
21. Armenti VT, Coscia LA, McGrory CH, Moritz MJ. National Transplantation Pregnancy Registry: update on pregnancy and renal transplantation. Nephrol News Issues 1998;12:19-23.
22. Armenti VT, Wilson GA, Radomski JS, Moritz MJ, McGrory CH, Coscia LA. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1999. Los Angeles: UCLA Immunogenetics Center, 1999:111-9.
23. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. In: Cecka JM, Terasaki PI, eds. Clinical transplants 2000. Los Angeles: UCLA Immunogenetics Center, 2000:97-105.
24. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, McGrory CH, Coscia LA. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. In: Cecka JM, Terasaki PI, eds. Clinical transplants 2003. Los Angeles: UCLA Immunogenetics Center, 2003:131-41.
25. Leavey SF, Weitzel WF. Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am 2002;31:107-19.
26. Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 1997;29:685-90.
27. Holley JL, Reddy SS. Pregnancy in dialysis patients: a review of outcomes, complications, and management. Semin Dial 2003;16:384-8.
28. Hou S. Pregnancy in dialysis patients: where do we go from here? Semin Dial 2003;16:376-88.
29. Canobbio MM, Perloff JK, Rapkin AJ. Gynecological health of females with congenital heart disease. Int J Cardiol 2005;98:379-87.
30. de Koning ND, Haagsma EB. Normalization of menstrual pattern after liver transplantation: consequences for contraception. Digestion 1990;46:239-41.
31. Cundy TF, O'Grady JG, Williams R. Recovery of menstruation and pregnancy after liver transplantation. Gut 1990;31:337-8.
32. Davison JM. Renal transplantation and pregnancy. Am J Kidney Dis 1987;9:374-80.
33. Davison JM. Idem. Dialysis, transplantation, and pregnancy. Am J Kidney Dis 1991;17:127-32.
34. Lessan-Pezeshki M, Ghazizadeh S, Khatami MR, et al. Fertility and contraceptive issues after kidney transplantation in women. Transplant Proc 2004;36:1405-6.
35. Hou S. Pregnancy in renal transplant recipients. Adv Ren Replace Ther 2003;10:40-7.
36. Davison JM, Bailey DJ. Pregnancy following renal transplantation. J Obstet Gynaecol Res 2003;29:227-33.
37. Riely CA. Contraception and pregnancy after liver transplantation. Liver Transpl 2001;7:Suppl 1:S74-S76.
38. Shlay JC, Mayhugh B, Foster M, Maravi ME, Baron AE, Douglas JM Jr. Initiating contraception in sexually transmitted disease clinic setting: a randomized trial. Am J Obstet Gynecol 2003;189:473-81.
39. Mastrobattista JM, Katz AR. Pregnancy after organ transplant. Obstet Gynecol Clin North Am 2004;31:415-28.
40. Zerner J, Doil KL, Drewry J, Leeber DA. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 1981;26:99-102.
41. EBPG Expert Group in Renal Transplantation. European best practice guidelines for renal transplantation. Section IV.10. Long-term management of the transplant recipient - pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002;17:Suppl 4:50-5.
42. Hou S. Pregnancy in chronic renal insufficiency and end stage renal disease. Am J Kidney Dis 1999;33:235-52.
43. McKay DB, Josephson MA, Armenti VT, et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005;5:1592-9.
44. Muirhead N, Sabharwal AR, Rieder MJ, Lazarovits AI, Hollomby DJ. The outcome of pregnancy following renal transplantation - the experience of a single center. Transplantation 1992;54:429-32.
45. Radomski JS, Ahlswede BA, Jarrell BE, et al. Outcomes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients. Transplant Proc 1995;27:1089-90.
46. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National Transplantation Pregnancy Registry - outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1994;57:502-6.
47. Armenti VT, Moritz MJ, Davison JM. Pregnancy in female pediatric solid organ transplant recipients. Pediatr Clin North Am 2003;50:1543-60.
48. Armenti VT, Moritz MJ, Cardonick EH, Davison JM. Immunosuppression in pregnancy: choices for infant and maternal health. Drugs 2002;62:2361-75.
49. Miniero R, Tardivo I, Curtoni ES, et al. Pregnancy after renal transplantation in Italian patients: focus on fetal outcome. J Nephrol 2002;15:626-32.
50. Miniero R, Tardivo I, Centofanti P, et al. Pregnancy in heart transplant recipients. J Heart Lung Transplant 2004;23:898-901.
51. Morales JM, Hernandez Poblete G, Andres A, Prieto C, Hernandez E, Rodicio JL. Uric acid handling, pregnancy and cyclosporin in renal transplant women. Nephron 1990;56:97-8.
52. Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 2005;48:372-86.
53. Davison JM, Milne JEC. Pregnancy and renal transplantation. Br J Urol 1997;80: Suppl 1:29-32.
54. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
55. Podymow T, August P, Umans JG. Antihypertensive therapy in pregnancy. Semin Nephrol 2004;24:616-25.
56. Jain AB, Reyes J, Marcos A, et al. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003;76:827-32.
57. Donaldson S, Novotny D, Paradowski L, Aris R. Acute and chronic lung allograft rejection during pregnancy. Chest 1996;110:293-6.
58. First MR, Combs CA, Weiskittel P, Miodovnik M. Lack of effect of pregnancy on renal allograft survival or function. Transplantation 1995;59:472-8.
59. Sturgiss SN, Davison JM. Effect of pregnancy on the long-term function of renal allografts: an update. Am J Kidney Dis 1995;26:54-6.
60. Miranda CT, Melaragno C, Camara NO, Pacheco-Silva A, Medina-Pestana PJ. Adverse effects of pregnancy on renal allograft function. Transplant Proc 2002;34:506-7.
61. Salmela KT, Kyllonen LE, Holmber C, Gronhagen-Riska C. Impaired renal function after pregnancy in renal transplant recipients. Transplantation 1993;56:1372-5.
62. Parry D, Hextall A, Banner N, Robinson V, Yacoub M. Pregnancy following lung transplantation. Transplant Proc 1997;29:629.
63. Parry D, Hextall A, Robinson VP, Banner NR, Yacoub MH. Pregnancy following a single lung transplant. Thorax 1996;51:1162-4.
64. Baron O, Hubaut J, Galetta D, et al. Pregnancy and heart-lung transplantation. J Heart Lung Transplant 2002;21:914-7.
65. Armenti VT, Herrine SK, Moritz MJ. Reproductive function after liver transplantation. Clin Liver Dis 1997;1:471-85.
66. Thomas AG, Burrows L, Knight R, Panico M, Lapinski R, Lockwood CJ. The effect of pregnancy on cyclosporine levels in renal allograft patients. Obstet Gynecol 1997;90:916-9.
67. Armenti VT, Ahlswede KM, Ahlswede BA, et al. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1995;59:476-9.
68. Jain AB, Shapiro R, Scantlebury VP, et al. Pregnancy after kidney and kidneypancreas transplantation under tacrolimus: a single center's experience. Transplantation 2004;77:897-902.
69. Armenti V, Moritz M, Davison JM. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998;19:219-32.
70. Szekeres-Bartho J, Csernus V, Hadnagy J, Pacsa AS. Immunosuppressive effect of serum progesterone during pregnancy depends on the progesterone binding capacity of the lymphocytes. J Reprod Immunol 1983;5:81-8.
71. Streilein JW. Peripheral tolerance induction: lessons from immune privileged sites and tissues. Transplant Proc 1996;28:2066-70.
72. Aluvihare VR, Kallikourdis M, Betz AG. Tolerance, suppression and the fetal allograft. J Mol Med 2005;83:88-96.
73. Sims CJ. Organ transplantation and immunosuppressive drugs in pregnancy. Clin Obstet Gynecol 1991;34:100-11.
74. Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus 2004;13:746-50.
75. Green TP, O'Dea RF, Mirkin BL. Determinants of drug disposition and effect in the fetus. Annu Rev Pharmacol Toxicol 1979;19:285-322.
76. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a metaanalysis. Transplantation 2001;71:1051-5.
77. Blanford AT, Murphy BE. In vitro metabolism of prednisone, dexamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977;127:264-7.
78. Anderson GG, Rotchell Y, Kaiser DG. Placental transfer of methylprednisolone following maternal intravenous administration. Am J Obstet Gynecol 1981;140:699-701.
79. Saarikoski S, Seppala M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973;115:1100-6.
80. Flechner SM, Katz AR, Rogers AJ, Van Buren C, Kahan BD. The presence of cyclosporine in body tissues and fluids during pregnancy. Am J Kidney Dis 1985;5:60-3.
81. Bourget P, Fernandez H, Delouis C. Accumulation of cyclosporine in the conceptus during the first trimester of pregnancy after liver transplantation. Transplantation 1991;51:1306-7.
82. Venkataramanan R, Koneru B, Wang CC, Burckart GJ, Caritis SN, Starzl TE. Cyclosporine and its metabolites in mother and baby. Transplantation 1988;46:468-9.
83. Shaheen FA, al-Sulaiman MH, al-Khader AA. Long-term nephrotoxicity after exposure to cyclosporine in utero. Transplantation 1993;56:224-5.
84. Jain A, Venkataramanan R, Fung JJ, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997;64:559-65.
85. Grimm VE. Effect of teratogenic exposure on the developing brain: research strategies and possible mechanisms. Dev Pharmacol Ther 1987;10:328-45.
86. Chambers CD, Braddock SR, Briggs GG, et al. Postmarketing surveillance for human teratogenicity: a model approach. Teratology 2001;64:252-61.
87. Rosenkrantz JG, Githens JH, Cox SM, Kellum DL. Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol 1967;97:387-94.
88. Githens JH, Rosenkrantz JG, Tunnock SM. Teratogenic effects of azathioprine (Imuran). J Pediatr 1965;66:959-61.
89. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985;92:233-9.
90. Williamson RA, Karp LE. Azathioprine teratogenicity: review of the literature and case report. Obstet Gynecol 1981;58:247-50.
91. Tallent MB, Simmons RL, Najarian JS. Birth defects in child of male recipient of kidney transplant. JAMA 1970;211:1854-5.
92. Mason RJ, Thomson AW, Whiting PH, et al. Cyclosporine-induced fetotoxicity in the rat. Transplantation 1985;39:9-12.
93. Pinsky L, DiGeorge AM. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science 1965;147:402-3.
94. Dieperink H, Steinbruchel D, Kemp E, Svendsen P, Starklint H. Cataractogenic effect of cyclosporin A: a new adverse effect observed in the rat. Nephrol Dial Transplant 1987;1:251-3.
95. Fein A, Vechoropoulos M, Nebel L. Cyclosporin-induced embryotoxicity in mice. Biol Neonate 1989;56:165-73.
96. Brown PA, Gray ES, Whiting PH, Simpson JG, Thomson AW. Effect of cyclosporin A on fetal development in the rat. Biol Neonate 1985;48:172-80.
97. Farley DE, Shelby J, Alexander D, Scott JR. The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. Transplantation 1991;52:106-10.
98. Physicians' desk reference. 60th ed. Montvale, N.J.: Thomson PDR, 2006:2751-8.
99. Registration Committee of the European Dialysis and Transplant Association. Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol 1980;87:839-45.
100. Cederqvist LL, Merkatz IR, Litwin SD. Fetal immunoglobulin synthesis following maternal immunosupression. Am J Obstet Gynecol 1977;129:687-90.
101. Holladay SD, Smialowicz RJ. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environ Health Perspect 2000;108:463-73.
102. Kainz A, Harabacz I, Cowlrick IS, Gadgil S, Hagiwara D. Analysis of 100 pregnancy outcomes in women treated systemically with tacrolimus. Transpl Int 2000;13:Suppl 1:S299-S300.
103. Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 2004;103:1091-4.
104. Hollander GA, Bierer B, Burakoff SJ. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function. Transfus Sci 1994;15:207-20.
105. Jenkins MK, Schwartz RH. Effects of cyclosporin A on T cell development and clonal deletion. Science 1988;241:1655-8.
106. Sakaguchi S, Sakaguchi N. Organspecific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J Immunol 1989;142:471-9.
107. Heeg K, Bendigs S, Wagner H. Cyclosporine A prevents the generation of single positive (Lyt2+L3T4-, Lyt2-L3T4+) mature T cells but not single positive (Lyt2+T3-) immature thymocytes in newborn mice. Scand J Immunol 1989;30:703-10.
108. Takahashi N, Nishida H, Hoshi J. Severe B cell depletion in newborns from renal transplant mothers taking immunosuppressive agents. Transplantation 1994;57:1617-21.
109. Di Paolo S, Schena A, Morrone LF, et al. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels. Transplantation 2000;69:2049-54.
110. Rose ML, Dominguez M, Leaver N, Lachno R, Yacoub MH. Analysis of T cell subpopulations and cyclosporine levels in the blood of two neonates born to immunosuppressed heart-lung transplant recipients. Transplantation 1989;48:223-6.
111. Pilarski LM, Yacyshyn BR, Lazarovits AI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation 1994;57:133-44.
112. Scott JR, Branch DW, Holman J. Autoimmune and pregnancy complications in the daughter of a kidney transplant patient. Transplantation 2002;73:815-6.
113. Sgro MD, Barozzino T, Mirghani HM, et al. Pregnancy outcome post renal transplanation. Teratology 2002;65:5-9.
114. Arsan A, Guest G, Gagnadoux MF, Broyer M. Pregnancy in renal transplantation: a pediatric unit report. Transplant Proc 1997;29:2479.
115. Pahl MV, Vaziri ND, Kaufman DJ, Martin DC. Childbirth after renal transplantation. Transplant Proc 1993;25:2727-31.
116. Ghahramani N, Attaipour Y, Ghods AJ. Chromosomal aberrations among offspring of female renal transplant recipients. Transplant Proc 1993;25:2190.
117. Bar J, Wittenberg C, Hod M, et al. Pregnancy outcome in renal allograft recipients in Israel. Isr J Med Sci 1996;32:1183-5.
118. Willis FR, Findlay CA, Gorrie MJ, Watson MA, Wilkinson AG, Beattie TJ. Children of renal transplant recipient mothers. J Paediatr Child Health 2000;36:230-5.
119. Stanley CW, Gottlieb R, Zager R, et al. Developmental well-being in offspring of women receiving cyclosporine post-renal transplant. Transplant Proc 1999;31:241-2.
120. Cheng SW, Chou HC, Tsou KI, Fang LJ, Tsao PN. Delivery before 32 weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-year developmental outcome. Early Hum Dev 2004;76:39-46.
121. Wallace IF, McCarton CM. Neurodevelopmental outcomes of the premature, small-for-gestational-age infant through age 6. Clin Obstet Gynecol 1997;40:843-52.
122. Warner TD, Dede DE, Garvan CW, Conway TW. One size still does not fit all in specific learning disability assessment across ethnic groups. J Learn Disabil 2002;35:500-8.
123. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-50.
124. Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity 2003;36:51-6.
125. Moretti ME, Sgro M, Johnson DW, et al. Cyclosporine excretion into breast milk. Transplantation 2003;75:2144-6.
126. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc 1982;14:605-9.